153 related articles for article (PubMed ID: 1863415)
1. Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
Clotet B; Sirera G; Romeu J; Gimeno JM; Jou A; Condom MJ; Tor J; Foz M
AIDS; 1991 May; 5(5):601-2. PubMed ID: 1863415
[No Abstract] [Full Text] [Related]
2. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of AIDS-related opportunistic infections (OIs).
Hardy WD
AIDS Clin Rev; 1989; ():125-50. PubMed ID: 2562216
[No Abstract] [Full Text] [Related]
4. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
[TBL] [Abstract][Full Text] [Related]
5. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
6. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.
Podzamczer D; Santín M; Jimenez J; Casanova A; Bolao F; Gudiol GR
AIDS; 1993 Apr; 7(4):501-6. PubMed ID: 8507417
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
8. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Opravil M; Joos B; Lüthy R
Antimicrob Agents Chemother; 1994 May; 38(5):1197-9. PubMed ID: 8067765
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Payen MC; De Wit S; Sommereijns B; Clumeck N
Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Hardy WD
AIDS Clin Rev; 1991; ():145-80. PubMed ID: 1651099
[No Abstract] [Full Text] [Related]
11. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Pneumocystis carinii pneumonia.
Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408
[No Abstract] [Full Text] [Related]
13. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
Falloon J; Lavelle J; Ogata-Arakaki D; Byrne A; Graziani A; Morgan A; Amantea MA; Ownby K; Polis M; Davey RT
Antimicrob Agents Chemother; 1994 Jul; 38(7):1580-7. PubMed ID: 7979291
[TBL] [Abstract][Full Text] [Related]
15. Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.
Carlin EM; Coker RJ; Goldin RD; Harris JR
Genitourin Med; 1993 Apr; 69(2):130-2. PubMed ID: 8509094
[TBL] [Abstract][Full Text] [Related]
16. [Cerebral toxoplasmosis in patients with AIDS].
Altés J; Salas A; Ricart C; Villalonga C; Riera M; Casquero P
Arch Neurobiol (Madr); 1989; 52 Suppl 1():121-6. PubMed ID: 2637654
[TBL] [Abstract][Full Text] [Related]
17. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E
AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236
[No Abstract] [Full Text] [Related]
18. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Opravil M; Pechère M; Lazzarin A; Heald A; Rüttimann S; Iten A; Furrer H; Oertle D; Praz G; Vuitton DA
Clin Infect Dis; 1995 Feb; 20(2):244-9. PubMed ID: 7742423
[TBL] [Abstract][Full Text] [Related]
19. Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.
Antinori A; Murri R; Tamburrini E; De Luca A; Ortona L
Lancet; 1992 Sep; 340(8822):788. PubMed ID: 1356193
[No Abstract] [Full Text] [Related]
20. Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
Gilman TM; Boylen CT; Sattler FR
Clin Pharm; 1989 Feb; 8(2):84, 87. PubMed ID: 2645082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
